Inhibikase Therapeutics Inc — Dividend History & Yield (NASDAQ:IKT) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Dividends per share ———— — Dividend yield % ———— — Payout ratio % ———— —

Haberler

BofA Securities, Inhibikase hissesi için Alım tavsiyesi ile analize başladı

BofA Securities initiates coverage on Inhibikase stock with Buy rating

Jefferies reiterates Buy rating on Inhibikase stock, citing faster FDA path

H.C. Wainwright, Inhibikase hissesi için Al tavsiyesi ile takibe başladı

H.C. Wainwright assumes coverage on Inhibikase stock with Buy rating

Monday’s Insider Activity: Top Executives Trade Shares at Tech Giants

Why Intuit Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Gap (NYSE:GAP), Elastic (NYSE:ESTC)

Inhibikase Therapeutics 100 milyon dolarlık halka arz fiyatlandırmasını açıkladı

Inhibikase Therapeutics prices $100 million public offering

Inhibikase Therapeutics hisseleri halka arz duyurusunun ardından düştü

Inhibikase Therapeutics stock falls after announcing public offering

Inhibikase Posts Wider Loss in Q2